# Evaluation of Efficacy and Safety of Roxadustat for the Treatment of Chemotherapy Induced Anemia

> **NCT04076943** · PHASE2 · COMPLETED · sponsor: **Kyntra Bio** · enrollment: 92 (actual)

## Conditions studied

- Chemotherapy Induced Anemia

## Interventions

- **DRUG:** Roxadustat

## Key facts

- **NCT ID:** NCT04076943
- **Lead sponsor:** Kyntra Bio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-20
- **Primary completion:** 2021-03-26
- **Final completion:** 2021-04-23
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2022-06-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04076943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04076943, "Evaluation of Efficacy and Safety of Roxadustat for the Treatment of Chemotherapy Induced Anemia". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT04076943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*